A renowned molecular biologist and an internationally acclaimed global health leader from UC San Francisco have been elected as members of the American Academy of Arts and Sciences.
April 25, 2014
July 23, 2012
Warner C. Greene, MD, a professor of medicine, microbiology and immunology at UCSFwho directs virology and immunology research at the UCSF-affiliated Gladstone Institutes, has joined with other global AIDS experts to release a locally affordable version of the world’s leading AIDS medical textbook.
May 01, 2012
Warner Greene, MD, PhD, a UCSF professor of medicine who directs virology and immunology research at the Gladstone Institutes, has been inducted as president of the Association of American Physicians.
March 14, 2012
President Barack Obama appointed UCSF AIDS expert Grant Colfax, MD, as the director of the Office of National AIDS Policy.
November 07, 2011
Low level HIV viremia – the presence of HIV in the bloodstream at levels undetectable by standard tests – was not associated with increased blood markers of inflammation or coagulation, or with increased risk of death, in adults taking highly active anti-retroviral therapy (HAART) for HIV infection, in a study led by researchers at the San Francisco VA Medical Center and UCSF.
October 25, 2011
The U.S. Health Resources and Services Administration has funded the UCSF Center for AIDS Prevention Studies to provide leadership and support to seven states implementing interventions to enhance HIV testing and diagnosis.
July 11, 2011
An international team led by researchers from UCSF and the nonprofit Vaccine and Gene Therapy Institute of Port St. Lucie, Fla., has received a major grant from the National Institutes of Health to develop a strategy to eradicate HIV from the body.
December 16, 2010
UCSF researchers have shown for the first time that the human fetal immune system arises from an entirely different source than the adult immune system, and is more likely to tolerate than fight foreign substances in its environment.
August 17, 2010
A joint project of UCSF and the Kenya Medical Research Institute has received $7 million—the first award of a five year grant that will total about $35 million—to expand its care and support of people affected by HIV/AIDS in Kenya.
July 02, 2010
HIV-infected patients who lost subcutaneous fat as a result of taking first-generation antiretroviral drugs still had strikingly less body fat than non-infected controls five years after switching to newer medications, according to a study led by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.